scholarly works

Permanent URI for this collectionhttps://repository.ui.edu.ng/handle/123456789/383

Browse

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Polypharmacy and factors associated with their prevalence among older patients attending a geriatric centre in South-West Nigeria
    (2018) Akande-Sholabi,W.; Adebusoye,L.; Olowookere,O.
    Background: Polypharmacy among older people in Nigeria are prominent issues of public health dimension. Polypharmacy especially in older people with multiple diseases often results in poor health status and outcomes. Objectives: To determine the prevalence and factors associated with polypharmacy among older patients attending the geriatric clinic. Methods: Cross sectional study of 400 elderly patients aged 60 years and above who presented at geriatric clinic, UCH, Ibadan. Polypharmacy was taken as concurrent consumption of =5 medications. Sociodemographic characteristics, lifestyle habits, attitudinal factors on medication understanding, medication pattern and intake were assessed through a questionnaire. Bivariate and multivariate analyses were carried out using SPSS 20 and alpha was set at 0.05. Results: Mean age of the respondents was 70.2 ± 5.9 years and 240 (60.0%) were females. The point prevalence of polypharmacy was 23.8%. The averagemedications consumed were 4 without sex difference. Logistic regression analysis showed that taking too many prescription medications (OR = 2.188; 95% CI = 1.014 – 4.808, p = 0.05), intentionally skipping my medications because they are too many (OR = 3.756; 95% CI = 1.354 – 10.424, p = 0.01) and receiving prescriptions from more than one physicians on regular basis (OR = 2.336; 95% CI = 1.058 – 5.155, p = 0.04) were the most significant factors associated with polypharmacy. Conclusion: Polypharmacy is common among older people in this setting. Healthcare workers should address the attitudinal, social and health related factors, which could lead to polypharmacy.
  • Thumbnail Image
    Item
    Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors afecting deprescribing process
    (Springer Open, 2023) Akande Sholabi, W.; Ajilore, C. O.; Ilori, T.
    Background Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of medication use review that helps to reduce polypharmacy, inappropriate medication uses and medication adverse events, thus ensuring medication optimization and improving healthrelated quality of life. As physicians are primarily responsible for prescribing and monitoring of drug therapy, their perception of deprescribing and knowledge of available deprescribing tools is highly important. This study aimed to explore physicians’ knowledge of deprescribing, deprescribing tools and factors that may afect the deprescribing process. Methods This was a cross-sectional survey carried out among 70 physicians in selected units of a teaching hospital in Nigeria between May and June 2022. Social-demographic information, knowledge of deprescribing and depre scribing tools were obtained using a self-administered, semi-structured questionnaire, while barriers and enablers of medication deprescribing were assessed with modifed Revised Patients’ Attitudes Towards Deprescribing (rPATD) Questionnaire. Descriptive and bivariate analyses were carried out using SPSS and α was set at p= 0.012), while knowledge of deprescribing tools was signif cantly associated with; awareness of the term “deprescribing” (p= 0.029), and daily encounters with older multimorbid patients (p=0.031). Very important factor afecting physicians deprescribing decisions include beneft of the medica tion. The most common barrier is lack of information for a full clinical picture of the patient. Conclusion The physicians had good knowledge of the term “deprescribing” and the steps to deprescribing. Specifc measures to target the barriers faced by the physicians in deprescribing medications and policies to implement physi cians use of existing guidelines to facilitate their deprescribing decisions are essential.